Identification of Key Genes in Purine Metabolism as Prognostic Biomarker for Hepatocellular Carcinoma.

Su, Wen-Jing; Lu, Pei-Zhi; Wu, Yong; Kalpana, Kumari; Yang, Cheng-Kun; Lu, Guo-Dong

Su, Wen-Jing; Lu, Pei-Zhi; Wu, Yong; Kalpana, Kumari; Yang, Cheng-Kun; Lu, Guo-Dong.

Afiliação

Su WJ; Department of Toxicology, School of Public Health, Guangxi Medical University, Nanning, China.
Lu PZ; Department of Toxicology, School of Public Health, Guangxi Medical University, Nanning, China.
Wu Y; Department of Toxicology, School of Public Health, Guangxi Medical University, Nanning, China.
Kalpana K; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
Yang CK; Department of Hepatobiliary Surgery, First Affiliated Hospital of Guangxi Medical University, Nanning, China.
Lu GD; Department of Toxicology, School of Public Health, Guangxi Medical University, Nanning, China.

Front Oncol ; 10: 583053, 2020.

Article em En | MEDLINE | ID: mdl-33520699

Palavras-chave

bioinformatics; biomarker; hepatocellular carcinoma; prognosis risk model; purine metabolism

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies / Prognostic_studies Idioma: En Revista: Front Oncol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google